Share Your Work
The Program Committee invites you to submit abstracts for papers and posters to be presented at the
6th Kaua’i Pain Conference.
Share your research, clinical outcomes, quality improvement initiative, or patient care strategy at the premier pain conference on the Hawai’ian Islands.
Original abstracts are sought in the following categories:
- Quality Improvement (QI) initiatives undertaken at your institution that improved clinical care, service, cost or patient outcomes
- Clinical advancements in pain management
- Therapeutic options for acute or chronic pain
- Improving patient communications and/or adherence to treatment plans
- Safe prescribing
- End of life care
- Targeted drug delivery
- Bioelectronic medicine, including neurostimulation
- Regenerative medicine
- Opioid use disorder and overdose treatment, including Medication-Assisted Treatment (MAT)
Download the Abstract Guide (above) for complete instructions.
A synopsis, limited to 100 words, must be included for each abstract. The synopsis can appear on a separate page and will not be counted against page limits.
Your synopsis should include a brief summary of the problem, methods, results, and conclusions. Synopses must only include text, without equations or images, and be without references or citations to items described in the full abstract.
Do your best to fit the abstract on a single page. This page does not need to include the synopsis.
Address each of the following sections within the abstract. In each section, answer the question listed below.
(Do not repeat the actual question in the body of your abstract.)
What do you call this project?
What content area best fits your abstract?
Why was this study/research/project performed?
How has this problem been studied?
What was the outcome or principal data and statistical analysis?
What is the relevance to clinical practice or future research?
References should follow the style outlined in the Abstract Guide.
Work submitted for presentation must include an acknowledgment of funding sources of commercial nature, and/or consulting or holding of significant equity in a company that could be affected by the results of the study.
Even if indicated elsewhere in the abstract, this must appear as the last sentence of the abstract and read “funded by…” and/or “equity in…”.
If nothing to disclose, state “Nothing to disclose by any author(s).”
Disclosure of funding and/or relationships must not include company logos